Abstract

BackgroundIntermittent preventive treatment during pregnancy (IPTp) with optimal doses (two+) of sulphadoxine-pyrimethamine (SP) protects pregnant women from malaria-related adverse outcomes. This study assesses the extent and predictors of uptake of optimal doses of IPTp-SP in six districts of Tanzania.MethodsThe data come from a cross-sectional survey of random households conducted in six districts in Tanzania in 2012. A total of 1,267 women, with children aged less than two years and who had sought antenatal care (ANC) at least once during pregnancy, were selected for the current analysis. Data analysis involved the use of Chi-Square (χ2) for associations and multivariate analysis was performed using multinomial logistic regression.ResultsOverall, 43.6% and 28.5% of the women received optimal (two+) and partial (one) doses of IPTp-SP respectively during pregnancy. Having had been counseled on the dangers of malaria during pregnancy was the most pervasive determinant of both optimal (RRR = 6.47, 95% CI 4.66-8.97) and partial (RRR = 4.24, 95% CI 3.00-6.00) uptake of IPTp-SP doses. Early ANC initiation was associated with a higher likelihood of uptake of optimal doses of IPTp-SP (RRR = 2.05, 95% CI 1.18-3.57). Also, women with secondary or higher education were almost twice as likely as those who had never been to school to have received optimal SP doses during pregnancy (RRR = 1.93, 95% CI 1.04-3.56). Being married was associated with a 60% decline in the partial uptake of IPTp-SP (RRR = 0.40, 95% CI 0.17-0.96). Inter-district variations in the uptake of both optimal and partial IPTp-SP doses existed (P < 0.05).ConclusionCounseling to pregnant women on the dangers of malaria in pregnancy and formal education beyond primary school is important to enhance uptake of optimal doses of SP for malaria control in pregnancy in Tanzania. ANC initiation in the first trimester should be promoted to enhance coverage of optimal doses of IPTp-SP. Programmes should aim to curb geographical barriers due to place of residence to enhance optimal coverage of IPTp-SP in Tanzania.

Highlights

  • Intermittent preventive treatment during pregnancy (IPTp) with optimal doses of sulphadoxine-pyrimethamine (SP) protects pregnant women from malaria-related adverse outcomes

  • Background characteristics A total of 1,267 women who had children aged less than two years and had sought antenatal care (ANC) at least once during pregnancy were analysed for the current question

  • The survey reported 66.0% coverage of at least one dose (IPTp-1) and 27.0% for the recommended dosage (IPTp-2) [3]. These findings reveal an outstanding failure to meet the Roll Back Malaria (RBM) target of 80% coverage of the recommended IPTp with SP (IPTp-SP) dosage by 2010 [25]

Read more

Summary

Introduction

Intermittent preventive treatment during pregnancy (IPTp) with optimal doses (two+) of sulphadoxine-pyrimethamine (SP) protects pregnant women from malaria-related adverse outcomes. Malaria in pregnancy (MiP) exerts major public health concerns worldwide, in malaria-endemic settings, and results in adverse health outcomes for both woman and foetus [1,2]. Low birth weight (LBW), infant mortality, maternal anaemia, spontaneous abortion, and stillbirth are documented as devastating health consequences of Plasmodium falciparum MiP [3]. Current evidence reveals further that exposure to IPTp with SP (IPTp-SP) and insecticidetreated bed nets (ITNs) are associated with reductions in both neonatal mortality and LBW [7]. IPTp-SP is acknowledged to be effective in reducing neonatal mortality [8]. Recent evidence from Malawi reveals that IPTp-SP enhances birth outcomes [9]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call